As the United States recalibrates its trade policies to combat what the Trump administration sees as “unfair” treatment by other countries, two significant industries have complained to US regulators about their treatment in Australia.
The tech industry – particularly Big Tech platforms such as Google and Meta – says it is being “coerced” into handing cash to Australian media companies. And the pharmaceutical industry is upset about low prices and delays in getting new treatments into the Australian market.
Why are we hearing about these complaints now? And what will they mean for Australia?
